AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1 Medical Dialogues Bureau13 April 2020 12:32 PM ISTKenilworth: AstraZeneca and MSD Inc. has announced that the US Food and Drug Administration (FDA) has approved the kinase inhibitor Koselugo...